Medical Devices Startups

Diagnoly develops real-time AI software that assists clinicians during fetal ultrasound scans to improve detection. Its product targets medical practitioners in prenatal diagnostics.

1 investor

Dialybrid develops vascular grafts for hemodialysis using Silkothane®, a hybrid material combining silk fibroin and polyurethane, targeting nephrologists and dialysis centers. The company focuses on advanced biomedical devices in the tissue engineering and regenerative medicine sector.

1 investor

Diamidex develops microbiological analysis solutions for water safety, including equipment, software, and reagents designed to detect and count targeted microorganisms with improved speed and accuracy for laboratory use.

1 investor

Dianyx Innovations makes t.e.s.a, an intraoral biosensor with five modalities that integrates into existing oral appliances and uses AI to convert biosignals into clinical-grade analytics for sleep, sports, and wellness. It serves patients, clinicians, and oral appliance manufacturers, providing a cloud analytics layer for sleep apnea (OSA/OAT) management and remote patient monitoring.

1 investor

Diasome develops metabolic therapies using its HDV platform to enable targeted drug delivery for treating diabetes, obesity, and metabolic diseases. The company focuses on translating therapeutic insights to restore metabolic function using endogenous mechanisms.

1 investor

Diatech Diabetes is a medical device company developing SmartFusion, a software platform and mobile app that monitors insulin infusion pumps for medication delivery failure and measures the accuracy of insulin delivery for people living with diabetes. The technology is in development and its core assets and IP have been acquired by DEKA Research & Development.

1 investor

Diatech Pharmacogenetics provides molecular testing and genetic analysis to enable precision medicine by matching patients with appropriate therapies based on their individual genetic profiles. The company serves healthcare providers and patients seeking personalized treatment options informed by pharmacogenomic data.

1 investor

DIATER develops diagnostic tools and therapeutic treatments for allergy patients using molecular immunotherapy techniques. The company manufactures personalized therapies for complex allergies and operates across Spain, Portugal, and Germany.

1 investor

DICOM Director develops medical imaging software that converts 2D CT and MRI scans into anatomically accurate 3D holograms viewable on augmented and virtual reality devices for clinicians. Its tools support diagnosis, therapy guidance, and secure study sharing between healthcare providers.

1 investor

Diesse develops and manufactures in-vitro diagnostic instruments and reagents for clinical laboratories, including automated ESR (erythrocyte sedimentation rate) analyzers, automated and manual immunoassay systems, and rapid diagnostic tests. Its product lines include VES-MATIC, CHORUS, AUTO-DAT, Enzywell, and iRapid.

1 investor

Digirad manufactures portable nuclear medicine imaging cameras for cardiology and general nuclear imaging applications. The company designs general-purpose SPECT/FAC imaging devices with emphasis on image quality and ease of use.

1 investor

Digistain develops imaging technology to grade breast cancer biopsies and assess cancer recurrence risk faster and more cost-effectively than traditional methods. The company serves breast oncologists and pathologists in clinical and diagnostic settings.

1 investor

Digital Anatomics develops AI-powered surgical planning software that generates personalized patient-specific guides for surgeons in complex procedures. The platform serves hospitals, surgical teams, and healthcare providers across Spain to improve surgical precision and patient outcomes.

1 investor

Dignitana is a Swedish medical technology company that develops and markets the DigniCap Scalp Cooling System, a patented cooling device designed to help cancer patients minimize hair loss during chemotherapy. The system is FDA-cleared since 2015 and addresses chemotherapy-induced alopecia to improve patient quality of life.

1 investor

DIH is a healthcare technology company that develops rehabilitation and robotic therapy devices and software (including the Hocoma product line) for the medical and healthcare industry. It serves clinical and rehabilitation providers with movement therapy and robotics-based solutions.

1 investor

Dim3 provides medical device software and hardware for clinical nutrition management, helping doctors, dietitians, and nurses detect malnutrition risks, plan personalized nutrition interventions, and track patient outcomes in real-time across healthcare settings.

1 investor

Dimension Bio is a biotechnology company developing regenerative therapeutics using its BioNidum platform, which combines materials science, 3D printing, and digital manufacturing to produce implantable and injectable biosynthetic scaffolds that promote tissue healing. Its products target clinical markets such as sports medicine, orthopedics, plastic and reconstructive surgery, aesthetics, dental, and neuro/spine, as well as cell delivery applications for conditions like liver failure and Type 1 diabetes.

1 investor

Directed Systems develops medical software using data science and physiological modeling to support patient monitoring and decision-making in hospital and emergency care, with a focus on reducing complications from cardiovascular instability during surgery and intensive care. Its products are designed with medical user input to provide real-time situational awareness for clinicians.

1 investor

DiscGenics develops an allogeneic, injectable disc progenitor cell therapy (IDCT/rebonuputemcel) for painful lumbar degenerative disc disease, currently advancing toward a Phase III clinical program. The company works in regenerative spine medicine and cell therapy, and collaborates on tissue-engineered intervertebral disc research.

1 investor

Dispatch Bio develops a universal immunotherapy treatment for solid tumors, combining engineered immunotherapy with a tumor-specific virus to improve cancer treatment outcomes.

1 investor

Dingke develops a range of vascular intervention devices, including balloon catheters for coronary, peripheral, and neurointervention procedures. The company manufactures and commercializes these products for hospitals and interventional centers globally.

1 investor

DLeader develops an AI-powered platform for automated drug discovery that accelerates the research and development process for pharmaceutical researchers. The platform uses generative AI tools to support and optimize the drug discovery workflow.

1 investor

DNAiTECH develops molecular diagnostic tests for point-of-care applications, including its PLACID platform combining paper-based LAMP-CRISPR technology, serving both medical and agricultural diagnostic markets. The company focuses on accessible diagnostics for conditions including ME/CFS, Long COVID, and veterinary/agritech applications.

1 investor

Doctorium is a telemedicine platform that connects patients with over 350 specialist doctors for online video consultations, second opinions, and triage. It provides clinical document sharing, medical reports, prescriptions, and post-consultation chat, serving patients in Italy.

1 investor